Comparative Assessment of Validated Prognostic Models in Estimation of 30 Day Mortality in Alcoholic HepatitisCorrespondence Address :
Dr. RK Kollipara,
Assistant Professor, Department of Medicine, Army College of Medical Sciences, Delhi Cantt-110010, New Delhi, India.
E-mail: firstname.lastname@example.org; email@example.com
Introduction: Alcoholic Hepatitis (AH) is a clinical syndrome seen in those with heavy alcohol intake and carries a very high mortality risk despite therapy. Patients with Severe Alcoholic Hepatitis (SAH) are currently advocated therapy with either Corticosteroids (CS) or Pentoxifylline (PTX). Various prognostic scores have been validated to assess for mortality risk. Studies comparing these validated prognostic scores for prediction of early mortality risk in Indian patients with SAH have been scarce.
Aim: To assess and compare utility of various prognostic scoring systems in predicting short term (30 day) mortality in patients with SAH.
Materials and Methods: This was a prospective comparative study and was approved by in house Ethics Committee of the Osmania general hospital, Hyderabad, Telangana, India. Patients 18 years or older with clinical alcoholic hepatitis, Aspartate Aminotransferase (AST)/Alanine Aminotransferase (ALT) ratio >2 with an AST level <500 U/L and Maddrey’s Discriminant Function (MDF) =32 were included in the study. Patients underwent clinical evaluation and investigations for severity assessment, presence of complications and associated infection. Various prognostic scores including Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP) score, MDF, Albumin-Bilirubin-International Normalised Ratio (INR)-Creatinine (ABIC) score, Glasgow Alcoholic Hepatitis Score (GAHS), United Kingdom End Stage Liver Disease (UKELD) and Sodium-MELD (Na-MELD) scores were calculated at admission while MELD, MDF and CTP were documented at day seven in patients who received therapy. The Area Under Receiver Operating Characteristic (AUROCs) for all the scores at the time of admission and for MELD, MDF and CTP at day seven were calculated and compared for 30 day mortality assessment.
Results: The 30 day mortality of SAH in the current study was 40%. Hepatorenal Syndrome (HRS), Liver Function Tests (LFTs), Prothrombin Time (PT), urea and creatinine and all scores including CTP, MELD, MDF, GAHS, ABIC, sodium-MELD and UKELD showed significant association with 30 day mortality on univariate analysis while UKELD and CTP showed most significance on multivariate analysis. At higher than current validated cut-off values, the specificity and Positive Predictive Value (PPV) of the scores was significantly increased with most scores having >90% specificity for 30 day mortality while sensitivity and the AUROCs of all scores were also increased, ranging from AUROC of 0.933 for UKELD at a value of 65.6 to an AUROC of 1.00 for a MELD score of 25.9. MELD at day seven at a cut-off of 28 showed 100% specificity with a PPV of 100 while MDF at day seven with best cut-off of 59.7 had 100% sensitivity and a Negative Predictive Value (NPV) of 100. However, CTP did not show significant dynamic change at day seven.
Conclusion: All evaluated scores at the time of admission and on day seven showed good sensitivity and specificity for assessment of 30 day mortality risk in patients with SAH. UKELD, CTP calculated on day one showed most significance on multivariate cox-regression analysis for 30 day mortality. At higher cut-off values, MDF, MELD, UKELD and GAHS can be used to stratify risk and identify patients with very high risk of 30 day mortality.
Discriminant function, Mortality, Pentoxifylline, Prednisolone
Sree geetha, RK kollipara, KP rao. COMPARATIVE ASSESSMENT OF VALIDATED PROGNOSTIC MODELS IN ESTIMATION OF 30 DAY MORTALITY IN ALCOHOLIC HEPATITIS. Journal of Clinical and Diagnostic Research [serial online] 2018 October [cited: 2019 Jan 23 ]; 12:OC09-OC13. Available from
Date of Submission: May 06, 2018
Date of Peer Review: May 30, 2018
Date of Acceptance: Aug 03, 2018
Date of Publishing: Oct 01, 2018
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)